Search
On this page:
Supporting cell culture media manufacturing at scale
Reliable, high-volume supply of cell culture media is an important dependency for vaccine and biologics manufacturers. Sourcing disruptions can affect production timelines and output consistency. Process engineers and supply chain leads seek media formats available at scale, produced to consistent specifications, and supported by a manufacturing infrastructure designed to meet increasing global demand.
The Grand Island, NY facility is a large-scale, manufacturing-focused site designed to support powder, liquid, and Advanced Granulation Technology (AGT) cell culture media production with the process controls and supply continuity that commercial bioprocessing programs depend on.
Facility highlights
This location represents a manufacturing-ready, regulatory-compliant environment designed to support the qualification requirements of commercial bioprocessing customers.
| Highlights | Detail |
| Products | Media, reagents, sera |
| Services | Media and analytical services, Gibco Rapid Prototyping Services |
| Regulatory status | FDA registered |
| Certifications | ISO 13485, 21 CFR 820 |
| Key manufacturing capabilities |
|
Capabilities that enhance media production
The Grand Island facility's powder and liquid manufacturing suites are used to produce cell culture media at scale, support format flexibility across dry powder and liquid formats, and reduce supply risk for customers.
Powder manufacturing
Grand Island's powder manufacturing suites support production of dry powder media (DPM) and AGT media.
Dry powder media
Dedicated animal origin-free (AOF) dry powder and AGT manufacturing areas support high-volume DPM production runs. A large ribbon blender and 300 ft³ blender with FitzMill™ technology are two of the assets featured in our virtual tour for large-batch processing across AOF powder media product lines.
Advanced Granulation Technology media
Gibco AGT media is a proprietary granulated dry powder format designed to support improved dispersion and reduced dust generation during reconstitution. A recently completed 45,000+ sq. ft. AOF manufacturing expansion doubled manufacturing capacity to address increasing demand from vaccine and biologics manufacturers.
Liquid manufacturing
Liquid manufacturing supports both animal origin-containing and AOF cell culture media and supplements. Infrastructure highlighted in our virtual tour include a large volume liquid pasteurization area, a liquid tank room and filtration system, a core liquid serum pre-filtration room, and a core liquid finishing and packaging area.
Cell culture media
The AO small blender (300–700 kg) and dedicated finishing and packaging lines are featured in our virtual tour and are among the assets used to bring finished liquid media to customers across product configurations.
Supplements
Supplemental liquid products support cell culture workflows by offering consistent, characterized additives produced under the same quality and process controls applied to primary liquid media manufacturing at the site.
Pilot labs and services
Grand Island's pilot laboratory capabilities are designed to support customers working to bridge the gap between development-scale formulations and manufacturing-scale media. Gibco Rapid Prototyping Services offers on-site support for non-GMP media prototyping, custom formulation evaluation, and format conversion, enabling process development teams to assess formulation candidates and media modifications before committing to full manufacturing runs. These services are structured to reduce development timelines and support more confident scale-up planning.
Discover our Grand Island, NY facility
Watch our facility overview video to learn about our dry powder media expansion project in Grand Island, designed to help decrease lead times for our customers, and explore our global cell culture media manufacturing network, including details of equivalency strategies to help ensure on-time, in-full order fulfillment, reduced lead times, risk reduction and the consistent, reliable quality you depend on.
View the Grand Island, NY Facility
Experience our 360° tours and look for informational hotspots and click them to learn more about equipment seen and the rooms you are visiting.
Additional bioprocessing resources
Bioprocessing resources
For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.